Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
This recent research highlights the potential impact of lipid accumulation on Alzheimer’s disease, focusing on the differential role of APOE gene variants in lipid transport within the brain, a crucial aspect that may shape future therapeutic directions.
Neurology April 9th 2024
GoodRx for Healthcare Professionals
Physicians should be aware of the evolving research regarding statins and dementia. Recent studies provide mixed evidence, with some suggesting a potential protective effect of statins against dementia, underscoring the necessity for individualized patient assessments.
Cardiology April 9th 2024
Mayo Clinic
Empower your patients with a multifaceted approach to cholesterol management, emphasizing the powerful combination of dietary adjustments, physical activity, and lifestyle changes alongside medical therapies.
All Specialties April 5th 2024
Consultant360
Stay updated on the USPSTF’s stance on lipid disorder screening in asymptomatic youth—a topic that directly impacts our strategies for early detection and intervention.
Endocrinology, Diabetes, Metabolism October 11th 2023
Annals of Internal Medicine
A recent Danish cohort study reveals that older adults (≥75 years) may experience a more pronounced LDL-C reduction with low- to moderate-intensity statins than their younger counterparts. This finding emphasizes the need to consider age when prescribing statin therapy.
Cardiology August 9th 2023
This summary of a January 2023 JACC article highlights the study finding that rosuvastatin was “vastly superior to… any of the six supplements studied in the trial.” The study compared rosuvastatin to cinnamon, garlic, turmeric, red yeast rice, fish oil, and plant sterols. Rosuvastatin yielded a reduction in cholesterol of nearly 38 percent in just 28 days. The supplements had little to no effect but were significantly more costly than the statin.
Cardiology February 8th 2023